Article Text

Download PDFPDF
Letter
Evaluation of the implementation of the 2012 ESPGHAN guideline of Coeliac disease in children: results of a retrospective study in the Netherlands
  1. Marjolijn Landman1,
  2. Sabine D M Theuns2,
  3. Herbert M van Wering3,
  4. Gerdien Tramper4,
  5. Marian van Ledden5,
  6. Edwin Rietveld6,
  7. Nico vd Lelij7,
  8. Isis Koolhoven Groeneweg8,
  9. Johanna Escher9,
  10. Michael Groeneweg10
  1. 1 Pediatrics, Maasstad Ziekenhuis, Rotterdam, The Netherlands
  2. 2 Pediatrics, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands
  3. 3 Pediatrics, Amphia Hospital, Breda, The Netherlands
  4. 4 Pediatrics, St Franciscus Vlietland, Rotterdam, The Netherlands
  5. 5 Pediatrics, Van Weel-Bethesda Ziekenhuis, Middelharnis, The Netherlands
  6. 6 Pediatrics, IJssellandziekenhuis, Rotterdam, The Netherlands
  7. 7 Stichting Reinier Haga Groep, Delft, The Netherlands
  8. 8 Bavo Europoort, Capelle aan den IJssel, The Netherlands
  9. 9 Pediatric Gastroentorology, Erasmus MC, Rotterdam, Netherlands
  10. 10 Pediatrics, Maasstad Hospital Rotterdam, Rotterdam, The Netherlands
  1. Correspondence to Mrs Marjolijn Landman, Pediatrics, Maasstad Ziekenhuis, Rotterdam 3079 DZ, The Netherlands; LandmanM{at}maasstadziekenhuis.nl

Statistics from Altmetric.com

We evaluated the effect of the 2012 The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guideline and the diagnostic algorithm on coeliac disease diagnosis in children in the South West region of the Netherlands. All children who were evaluated for coeliac disease between 1 January 2012 (implementation date of the guideline1) and 1 January 2014 were included in this retrospective evaluation. Patients were diagnostic tested in seven general hospitals and in one university hospital. A total of 253 …

View Full Text

Footnotes

  • Contributors ML: principal investigator, data collection, writer article. SDMT: data collection and review article. HMvW: data collection and review article. GT: data collection and review article. MvL: data collection and review article. ER: data collection and review article. NvdL: data collection and review article. IKG: data analysis. JE: data collection and review article. MG: data collection and review article.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.